We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Chemotherapy periodization to maximize resistance training adaptations in oncology

    Introduction

    Engaging in exercise programs during cancer treatment is challenging due to the several chemotherapy-induced side effects. Using a...

    Jonathan H. C. Nunes, Paola S. Cella, ... Rafael Deminice in Cancer Chemotherapy and Pharmacology
    Article 15 August 2023
  2. Hsa_circ_0041150 serves as a novel biomarker for monitoring chemotherapy resistance in small cell lung cancer patients treated with a first-line chemotherapy regimen

    Purpose

    To explore the potential of circRNAs as biomarkers in non-invasive body fluids for monitoring chemotherapy resistance in SCLC patients.

    ...
    Yang Zhang, Fengmei Chao, ... Zuojun Shen in Journal of Cancer Research and Clinical Oncology
    Article Open access 28 August 2023
  3. Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study

    Background

    Advanced lung adenocarcinoma patients often develop resistance to EGFR tyrosine kinase inhibitors (EGFR-TKIs), leaving uncertainties...

    Kan Jiang, Lin Wu, ... Gen Lin in BMC Pulmonary Medicine
    Article Open access 24 February 2024
  4. Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia

    Chemotherapy-resistant acute myeloid leukemia (AML), frequently driven by clonal evolution, has a dismal prognosis. A genome-wide CRISPR knockout...

    Victoria Y. Ling, Jasmin Straube, ... Steven W. Lane in Leukemia
    Article 18 November 2022
  5. M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma

    Doxorubicin and platinum are widely used in the frontline treatment of osteosarcoma, but resistance to chemotherapy limits its curative effect. Here,...

    Mingyu He, Yang Wang, ... Lei Yang in Oncogene
    Article 01 December 2023
  6. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy

    Background

    Patients (pts) with locally advanced gastric adenocarcinoma (LAGA) often receive neoadjuvant chemotherapy. A minority of patients do not...

    Changhwan Yoon, Ju Lu, ... Sam S. Yoon in Journal of Gastrointestinal Surgery
    Article 10 January 2023
  7. Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers

    Purpose

    Resistance to chemotherapy and radiotherapy is the primary cause of a poor prognosis in oncological patients. Researchers identified many...

    Dawid Dorna, JarosƂaw Paluszczak in Journal of Cancer Research and Clinical Oncology
    Article Open access 15 July 2023
  8. Prognostic Factors Associated with hCG Remission and Chemotherapy Resistance in Patients with High-Risk Gestational Trophoblastic Neoplasia

    Objective

    The main aim of this study was to assess the effect of various clinical factors on time to hCG remission and chemoresistance among women...

    S. V. Tejas, V. R. Pallavi, ... S. K. Rajshekhar in Indian Journal of Gynecologic Oncology
    Article 30 October 2022
  9. Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma

    The patients with relapsed and refractory diffuse large B-cell lymphoma (DLBCL) have poor prognosis, and a novel and effective therapeutic strategy...

    **-Ya Li, Ji-Chuan Wu, ... Lan Wang in Leukemia
    Article Open access 09 November 2022
  10. Albumin/fibrinogen ratio, a predictor of chemotherapy resistance and prognostic factor for advanced gastric cancer patients following radical gastrectomy

    Background

    The objective of this study was to investigate potential predictors of chemotherapy resistance in patients with advanced gastric cancer...

    Guojun Zhao in BMC Surgery
    Article Open access 28 May 2022
  11. Real-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy

    Introduction

    Docetaxel is an established standard therapy after osimertinib and platinum-based doublet chemotherapy (Pt-doublet) for locally advanced...

    Hidetoshi Hayashi, Makoto Nishio, ... Mami Kasahara-Kiritani in Advances in Therapy
    Article Open access 12 August 2023
  12. Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling

    Chemotherapy remains a widely used cancer treatment. Acquired drug resistance may greatly reduce the efficacy of treatment and means to overcome it...

    Mariusz Bodzioch, Piotr Bajger, Urszula Foryƛ in Journal of Cancer Research and Clinical Oncology
    Article Open access 29 May 2021
  13. Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study

    Background

    Accurate pre-treatment prediction of neoadjuvant chemotherapy (NACT) resistance in patients with locally advanced gastric cancer (LAGC) is...

    Jiayi Zhang, Yanfen Cui, ... **aotang Yang in Gastric Cancer
    Article 06 August 2022
  14. Short-term effects of a new resistance exercise approach on physical function during chemotherapy after radical breast cancer surgery: a randomized controlled trial

    Background

    Approximately 30% of post-operative breast cancer patients develop shoulder joint movement disorders affecting routine upper limb movement....

    Ming Huo, **n Zhang, ... Chao Wang in BMC Women's Health
    Article Open access 05 March 2024
  15. m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer

    Small-cell lung cancer (SCLC) is a devastating subtype of lung cancer with few therapeutic options. Despite the advent of immunotherapy,...

    Zhihui Zhang, Chaoqi Zhang, ... Jie He in Journal of Hematology & Oncology
    Article Open access 10 November 2021
  16. Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients

    Background

    Preclinical studies prove that short-term fasting secures healthy cells against chemotherapy side effects and makes malignant cells more...

    Enas M. Omar, Gamal A. Omran, ... Noha M. El-Khodary in Journal of the Egyptian National Cancer Institute
    Article Open access 12 September 2022
  17. Urachal mixed adenocarcinoma and small cell neuroendocrine carcinoma with widespread metastasis and resistance to chemotherapy: a case report

    Neuroendocrine carcinoma arising from the urachus is extremely rare. We describe a case of a 33-year-old gentleman who presented with hematuria and...

    Sarah Obiedat, Khaled Murshed, ... Issam Al Bozom in Diagnostic Pathology
    Article Open access 14 June 2024
Did you find what you were looking for? Share feedback.